A practical reference on GLP-1 receptor: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-03-24 and is reviewed periodically as new material appears.
Tirzepatide is a synthetic peptide that acts as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. The molecule contains 39 amino acids and features a C20 fatty diacid moiety attached via a linker, which promotes albumin binding and extends its circulating half-life. Its sequence incorporates non-natural amino acids and modifications that reduce susceptibility to degradation by dipeptidyl peptidase-4. This dual receptor activity distinguishes it from selective GLP-1 receptor agonists.
The GIP receptor is expressed in pancreatic islets, adipose tissue, and the central nervous system, while GLP-1 receptors are found in pancreatic islets, the gastrointestinal tract, and the brain. Activation of both receptors can enhance glucose-dependent insulin secretion and reduce glucagon release. The relative contribution of each receptor to the overall pharmacological effect remains an area of ongoing investigation. Preclinical studies suggest that GIP receptor agonism may modulate appetite and energy balance, but the precise mechanisms in humans are not fully established.
The compound first appeared in the scientific literature as an investigational agent for type 2 diabetes. Clinical development proceeded through phase 1, phase 2, and phase 3 programs that measured glycemic control as a primary endpoint while recording body weight as a secondary outcome. Regulatory approval in the United States followed in 2022 for glycemic control, and a separate indication for chronic weight management was added later. Subsequent trials have examined cardiovascular outcomes in adults with elevated cardiovascular risk. Debates continue over how much of the observed effect derives from each receptor arm.
Structural work on the molecule centers on a C20 fatty diacid moiety attached through a linker to the peptide backbone. This side chain promotes reversible binding to serum albumin, which slows renal clearance and supports a prolonged action profile. The peptide backbone incorporates aminoisobutyric acid substitutions that limit recognition by digestive enzymes. Together these modifications produce a molecule that is stable enough for subcutaneous delivery but still dependent on careful manufacturing control. Analytical characterization of the active pharmaceutical ingredient typically follows the conventions used for other synthetic peptides.
Tirzepatide is a synthetic peptide composed of 39 amino acids. It acts as a dual agonist at two incretin receptors, the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. The molecule was designed by modifying the native sequence of glucose-dependent insulinotropic polypeptide to improve metabolic stability and extend its circulation time. Its structure includes several non-natural amino acid residues and a fatty acid side chain. These features distinguish it from earlier single-receptor incretin analogs studied in the same period.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Dual GIP/GLP-1 receptor agonist |
| Amino acid count | 39 | Contains non-natural residues |
| Modification | C20 fatty diacid | Attached via linker; promotes albumin binding |
| Half-life | Approximately 5 days | Supports once-weekly dosing |
| Primary route | Subcutaneous injection | Not for intravenous use |
Clinical research programs have evaluated tirzepatide in adults with type 2 diabetes and in adults with obesity or excess weight. Trials generally reported reductions in glycated hemoglobin and body weight across treatment periods of several months. Since these studies enrolled defined populations under controlled conditions, the findings describe group averages rather than individual outcomes. Open questions include the durability of effects after treatment stops, variation among subgroups, and the long-term consequences of sustained dual receptor stimulation. Published trial summaries should be consulted for exact measurements rather than secondary accounts.
Tirzepatide is a synthetic peptide built from 39 amino acid residues. Its backbone derives from the native glucose-dependent insulinotropic polypeptide sequence, altered at several positions to resist enzymatic cleavage. A fatty diacid group attached through a linker extends plasma residence time by promoting reversible binding to serum albumin. The molecule carries a net negative charge near physiological pH and has a reported molecular weight close to 4813 daltons. These features separate it from shorter incretin analogs and account for its prolonged dosing interval.
Pharmacologically, tirzepatide activates two distinct G protein-coupled receptors: the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. Binding at each target triggers cyclic AMP accumulation and downstream signaling in pancreatic beta cells, adipose tissue and the central nervous system. Because the two pathways overlap only partially, the combined effect on insulin secretion, glucagon suppression and appetite signaling differs from that of selective single-receptor compounds. Affinity is not equal across the two targets, and the clinical meaning of that imbalance remains an area of active study.
Cold-chain handling is standard for formulated product, with dry powder stored frozen and ready-to-use solutions refrigerated. Light exposure is minimized because photodegradation of certain amino acid side chains is possible. Shipping and temperature-excursion studies are used to establish whether short deviations affect quality attributes. Documentation supplied with research material usually includes a certificate of analysis listing purity, identity confirmation, and water or residual solvent content. Users are expected to confirm that material meets the stated specification before use.
Identity and purity of tirzepatide are assessed mainly by reversed-phase high-performance liquid chromatography with ultraviolet detection, often paired with mass spectrometry. Because the molecule carries several modifications, gradient conditions are adjusted to resolve the intact peptide from deamidation and oxidation products. Enzymatic digestion followed by peptide mapping confirms the primary sequence and locates specific modifications. Quantitation in biological matrices typically uses liquid chromatography with tandem mass spectrometry after solid-phase extraction. Immunoassays are used less often, since antibody cross-reactivity with closely related peptides can bias results.
Like most synthetic peptides of this size, the material is commonly supplied as a lyophilised powder that appears white to off-white. It dissolves in aqueous buffers and in mixtures of water with a small proportion of organic solvent, though the fatty acid portion reduces solubility in pure water relative to short peptides. Hygroscopic behaviour is reported for many peptide powders, so weighing is usually performed quickly and under controlled humidity. Working solutions are typically prepared fresh and kept cold.
Long-term storage of lyophilised peptide powder is generally at minus twenty degrees Celsius or colder, with desiccant and protection from light. Short-term storage at two to eight degrees Celsius is common during active use. In solution, stability depends strongly on pH, concentration, and the presence of preservatives, and hydrolysis or aggregation can develop over weeks. Published stability data specific to this molecule are limited, so recommended conditions for research material are usually extrapolated from general peptide handling practice rather than from a dedicated study.
Bulk peptide material is normally characterised by reversed-phase high-performance liquid chromatography, which separates the target sequence from truncation products and other closely related impurities. Ultraviolet detection near 214 nanometres is common because the peptide backbone absorbs in that region. Mass spectrometry, usually electrospray ionisation coupled to a mass analyser, is used to confirm the molecular mass. Because the molecule carries a lipophilic side chain, gradient methods often need a relatively high organic modifier fraction to elute it within a practical retention window.
定量分析的主流方法是反相高效液相色谱联用紫外或质谱检测，利用肽在疏水固定相上的保留行为确定纯度与含量。对于生物基质中的浓度测定，常采用液相色谱串联质谱，并配合固相萃取或蛋白沉淀进行样品前处理。免疫分析法也可使用，但可能受到结构相关肽的交叉反应干扰。
纯度评估通常综合反相色谱、体积排阻色谱与质谱三方面信息：前者反映疏水性杂质，后者反映聚集体，质谱则确认分子量与主要降解产物。有关降解途径的完整图谱——例如脱酰胺、氧化与水解各占多大比例——在不同储存条件下仍有差异，属于需要逐案验证的问题。
=== Australia === From 1 July 2012 Chinese medicine practitioners must be registered under the national registration and accreditation scheme with the Chinese Medicine Board of Australia and meet the Board's Registration Standards, to practice in Australia.
==== Towards an energetic definition of civilization ==== In 1980, Nikolai Kardashev published a second article entitled Strategies of Searching for Extraterrestrial Intelligence: A Fundamental Approach to the Basic Problem, in which he stated that:Detection and studies of extraterrestrial civilizations constitute a problem of immense significance for the progress of humanity and for its culture and philosophy. The discovery of intelligent life in the Universe would provide a guideline to the possible development of our civilization over astronomical time spans.
Sarcomas are typically divided into two major groups: bone sarcomas and soft-tissue sarcomas, each of which has multiple subtypes. In the United States, the American Joint Committee on Cancer (AJCC) publishes guidelines that classify the subtypes of sarcoma. These subtypes are as follows:
Further, due to the small size of available samples, the melting point of einsteinium was often deduced by observing the sample being heated inside an electron microscope. Thus, surface effects in small samples could reduce the melting point. The metal is trivalent and has a noticeably high volatility. In order to reduce the self-radiation damage, most measurements of solid einsteinium and its compounds are performed right after thermal annealing. Also, some compounds are studied under the atmosphere of the reductant gas, for example H2O+HCl for EsOCl so that the sample is partly regrown during its decomposition. Apart from the self-destruction of solid einsteinium and its compounds, other intrinsic difficulties in studying this element include scarcity—the most common 253Es isotope is available only once or twice a year in sub-milligram amounts—and self-contamination due to rapid conversion of einsteinium to berkelium and then to californium at a rate of about 3.3% per day:
Sources: en.wikipedia.org
==== Robots ==== Modern robotics have made huge progress and contribution to healthcare. Robots can help doctors in performing variety tasks. Robotics adoption is increasing tremendously in hospitals. The following are different ways to improve healthcare by using robots:
In chemistry, solid-phase synthesis is a method in which molecules are covalently bound on a solid support material and synthesised step-by-step in a single reaction vessel utilising selective protecting group chemistry. Benefits compared with normal synthesis in a liquid state include:
=== Long-term effects === Regular use of large amounts of kava may cause mood swings, apathy, dry, scaly skin, malnutrition, weight loss, increased susceptibility to infections, and shortness of breath. Long-term use has also been associated with liver damage; however, the available evidence remains inconclusive. The risk is higher with alcoholic or acetonic extracts, or concentrated forms like pills. Water-based kava extracts in moderate doses are considered safer, but should not be consumed with alcohol, particularly in those with a history of liver issues.
Peukert was one of the first historians to make a detailed examination of the persecution of the Romani. Peukert often compared Nazi policies towards Roma with Nazi policies towards Jews. On the basis of his research into popular attitudes towards "outsiders" in the Third Reich, Peukert came up with the concept of "everyday racism" to explain the contrast between the "normality" of life for most Germans while genocide was being committed. By "everyday racism", Peukert meant a certain causal racism that allowed people to accept violence being committed against those considered to be different. Peukert wrote about: "a fatal continuum of discrimination, selection, and rejection/elimination, whose monstrous consequences perhaps remained hidden from most contemporaries in their totality but whose inhumane daily racism was not only constantly and everywhere present but until today has not been critically worked through". As part of his research into "everyday racism", Peukert explored how ordinary people use of disparaging language to describe the homeless allowed them to see as justified the mass incarceration of the homeless into the concentration camps under the grounds that the homeless were part of the "asocial" threatening the volksgemeinschaft. In his research into opinion during the war years, Peukert noted that thousands of Polish and Frenchmen were brought to work in Germany as slave laborers to replace German men who been called up into the Wehrmacht.
The AGA does not recommend extensive pre-procedural testing, including repeated measurements of PT/INR or platelet count, before patients with stable cirrhosis undergo common gastrointestinal procedures. Nor do they suggest the routine use of blood products, such as platelets, for bleeding prevention. Cirrhosis is stable when there are no changes in baseline abnormalities of coagulation lab values. For patients with stable cirrhosis and low platelet count undergoing common low-risk procedures, the AGA does not recommend the routine use of thrombopoietin receptor agonists for bleeding prevention. In hospitalized patients who meet standard guidelines for clot prevention, the AGA suggests standard prevention. The AGA does not recommend routine screening for portal vein thrombosis. If there is a portal vein thrombosis, the AGA suggests treatment by anticoagulation. In the case of cirrhosis with atrial fibrillation, the AGA recommends using anticoagulation over no anticoagulation.
Sources: en.wikipedia.org
4-Methylbenzylidene camphor (USAN Enzacamene) Tinosorb S (USAN Bemotrizinol, INCI Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine) Tinosorb M (USAN Bisoctrizole, INCI Methylene Bis-Benzotriazolyl Tetramethylbutylphenol) Butyloctyl Salicylate (Tradename HallBrite BHB - [1]) Hexadecyl Benzoate Butyloctyl Benzoate HallBrite PSF (INCI Undecylcrylene DimethiconeE) Mexoryl SX (USAN Ecamsule, INCI Terephthalylidene Dicamphor Sulfonic Acid) Synoxyl HSS (INCI Trimethoxybenzylidene Pentanedione) Corapan TQ (INCI Diethylhexyl 2,6-Naphthalate) Parsol SLX (INCI Polysilicone-15) Oxynex ST (INCI Diethylhexyl Syringylidene Malonate Polycrylene (INCI Polyester-8) SolaStay S1 (INCI Ethylhexyl Methoxycrylene) Octyl Salicylate (INCI Ethylhexyl Salicylate) Complexing avobenzone with cyclodextrins may also increase its photostability. Formulations of avobenzone with hydroxypropyl-beta-cyclodextrin have shown significant reduction in photo-induced degradation, as well as decreased transdermal penetration of the UV absorber when used in high concentrations. The photostability of avobenzone is further increased when sunscreens are formulated with antioxidant compounds. Mangiferin, glutathione, ubiquinone, vitamin C, vitamin E, beta-carotene and trans-resveratrol have all demonstrated some ability to protect avobenzone from photodegradation. The stability and efficacy of avobenzone seems to continue to increase as a greater amount of antioxidants are added to the sunscreen.
Chemical engineering – Engineering discipline focused on the design and operation of chemical plants Chemical reactor – Enclosed volume where interconversion of compounds takes place Medical science liaison – Connecting biotechnology and health care Pharmaceutical formulation – Process for producing a final medicinal product Pharmaceutical packaging – Packaging for pharmaceutical preparationsPages displaying short descriptions of redirect targets Site Master File – Synthesis of pharmaceutical drugsPages displaying short descriptions of redirect targets 3D drug printing – 3D printing of customized medicationPages displaying short descriptions of redirect targets
A plot of ion abundance as a function of mass-to-charge ratio is called a mass spectrum. It can be produced by a mass spectrometer instrument. The mass spectrum can be used to determine the quantity and mass of atoms and molecules. Tandem mass spectrometry is used to determine molecular structure.
=== Pharmacokinetics === The absorption of omeprazole takes place in the small intestine and is usually completed within three to six hours. The systemic bioavailability of omeprazole after repeated doses is about 60%. Omeprazole has a volume of distribution of 0.4 L/kg. It has high plasma protein binding of 95%. Omeprazole is completely metabolized by the cytochrome P450 system, mainly in the liver, by CYP2C19 and CYP3A4 isoenzymes. Identified metabolites are the sulfone, the sulfide, and hydroxy-omeprazole. About 77% of an orally given dose is excreted as metabolites in the urine, and the remainder is found in the feces, primarily originating from bile secretion. Omeprazole has a half life of 0.5 to 1 hour.
==== 2023 Six Nations Championship ==== 4 February – Wales 10–34 Ireland 11 February – Ireland 32–19 France 25 February – Italy 20–34 Ireland 12 March – Scotland 7–22 Ireland 18 March – Ireland won the Grand Slam, after a 29–16 victory over England at the Aviva Stadium.
Sources: en.wikipedia.org
It activates both GIP and GLP-1 receptors. This dual action differentiates it from selective GLP-1 agonists.
It is given as a subcutaneous injection. Its long half-life supports weekly dosing.
No, it is synthetic. It contains non-natural amino acids and a fatty acid modification.
It activates both the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. This dual activity separates it from agents that act on only one of the two receptors. The relative contribution of each receptor to clinical effects remains an open area of study.